コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 95% CI, .68-.86] and 0.75 [95% CI, .68-.82], respectively).
2 pN-stage (DeltaAIC 17.9 versus 6.2 and 17.2, respectively).
3 ared to placebo ( P < 0.0161 and P < 0.0001, respectively).
4 nd after 1 (T1) and 3 (T3) months of ageing, respectively).
5 rtality risks (log rank P=0.004 and P=0.003, respectively).
6 positivity remained constant (15.7% v 15.5%, respectively).
7 ans ( approximately 4 and approximately 7 d, respectively).
8 , 95%CI = 1.3-6.4; and 2.4, 95%CI = 1.3-4.5, respectively).
9 free survival (DFS) (p = 0.00001; p = 0.01, respectively).
10 d 1.05 +/- 0.99 in 10(8) normal nucleotides, respectively).
11 332mg/100g extract and 95.46mg/100g extract, respectively).
12 .461, p = 0.005 and beta = 1.902, p = 0.002, respectively).
13 -0.92, P = .02, and .31; 0.10-0.94, P = .04, respectively).
14 etween the two groups (102.7 v 115.7 months, respectively).
15 ons (absolute success and qualified success, respectively).
16 hypervigilance and impulse control deficits, respectively).
17 nits] and 7.0 units [CI, 3.4 to 10.5 units], respectively).
18 1374, and HR = 1.17 [0.96-1.42], p = 0.1206, respectively).
19 Young Adults] and BioImage; n=1154 and 4392, respectively).
20 03 copies/mL and 0.01-551.9 x 103 copies/mL, respectively).
21 ntigen and cytology ( P < .001 and P = .003, respectively).
22 ily observed humidity forcing (4.4% and 2.6% respectively).
23 CI) 3.68 (1.06-12.83) and 8.65 (2.46-30.49), respectively).
24 and HOMA-B (P-interaction = 0.006 and 0.002, respectively).
25 , 1.38-16.22] and 4.54 [95% CI, 1.40-14.80], respectively).
26 and antiparallel G-quadruplex in K+ and Na+, respectively).
27 [95% CI, 54%-80%] vs 76% [95% CI, 72%-80%], respectively).
28 usted hazard ratio, 0.92; 95% CI, 0.76-1.12, respectively).
29 and fracture risk (P = 0.004 and 4.0 x 10-4, respectively).
30 atforms (Solo-MFP, Duet-MFP and Quintet-MPF, respectively).
31 er (P for trend <0.0001, <0.0001, and 0.009, respectively).
32 = .006, P = .0001, P = .002, and P = .0001, respectively).
33 on (p = 0.329 and p = 0.291 for CKD and CVD, respectively).
34 5%, increase of 0.05%, and decrease of 0.3%, respectively).
35 elopment (P = 0.04, 0.01, 0.04, 0.004, 0.01, respectively).
36 rometry (ICP-MS) and high-resolution ICP-MS, respectively.
37 subunits in the LS or HS nAChR populations, respectively.
38 volved in salt response in roots and leaves, respectively.
39 s of minimal change glomerulopathy and FSGS, respectively.
40 lences of ID and IDA were 28-85% and 21-35%, respectively.
41 of MA in the 3 groups was 40%, 0%, and 8.3%, respectively.
42 malian target of rapamycin (mTOR) signaling, respectively.
43 with and without previous glaucoma surgery, respectively.
44 n and the implications for males and females respectively.
45 g 21% and 11% in single- and double-strands, respectively.
46 ing via VEGF receptor (VEGFR)-2 and VEGFR-3, respectively.
47 for delta(13)C and delta(18)O measurements, respectively.
48 for oxamyl the LOQs were 2.9 and 0.67mug/kg, respectively.
49 scular tissue formation and root initiation, respectively.
50 al periods 120 and 244 thousand years ago, respectively.
51 te accumulation was 0.77%, 2.70%, and 6.33%, respectively.
52 25 mW cm(-2) at 500, 550, and 600 degrees C, respectively.
53 as clinically relevant if >/=10% and >/=5%, respectively.
54 Ns could be identified in PET and fMRI data, respectively.
55 determination were 0.039 and 0.015mugg(-1), respectively.
56 in ligand dependent and independent manners respectively.
57 is or Amgen, the makers of ZA and denosumab, respectively.
58 tion factor 2 (RUNX2) transcription factors, respectively.
59 on in xenograft and orthotopic mouse models, respectively.
60 liosarcoma tumors or glioma stem-like cells, respectively.
61 the method were found to be 5ppb and 0.5906% respectively.
62 /- 4.1%, 58.8% +/- 9.8%, and 16.1% +/- 7.4%, respectively.
63 tained 67-68%, 39-41%, and 15-17% 3D BA-RSA, respectively.
64 presented with early and late/very late ST, respectively.
65 rugs, accounted for 9 and 24% of total SLIT, respectively.
66 ically deleted in heart and striated muscle, respectively.
67 xide (EO) unit numbers (P) of 25, 34 and 25, respectively.
68 AR) and X-linked EDA receptor (XEDAR/EDA2R), respectively.
69 or, and panuveitis in 2, 13, and 6 patients, respectively.
70 , PFHpA, PFOA, PFNA, PFDA, PFUnDA, and PFOS, respectively.
71 overall survival rates were 19.4% and 21.5%, respectively.
72 pillary constriction and lens accommodation, respectively.
73 BC with a bioavailability of 0.13% and 0.49% respectively.
74 s=0.65 (95% confidence interval, 0.52-0.80), respectively.
75 ngths are calculated to be 3.21 and 4.70 eV, respectively.
76 f 6 and 70 nM for human HGPRT and Pf HGXPRT, respectively.
77 DBP were 139.7+/-15.6 and 78.1+/-11.9 mm Hg, respectively.
78 ecular weights of 689, 851, 1013 and 1151Da, respectively.
79 ted VE was 67% (40%-82%) and 43% (-12%-71%), respectively.
80 that were also silenced and underexpressed, respectively.
81 ing Cre from the Lyz2 or the BGLAP promoter, respectively.
82 ls ranged from 0.015-0.10 h(-1) to 7.0-47 h, respectively.
83 nic diet (HCD) or matching normal diet (ND), respectively.
84 the yellow and red-violet varieties analyzed respectively.
85 to 62%), and 97.1% (95% CI, 92.8% to 98.9), respectively.
86 on-randomized Studies of Interventions tool, respectively.
87 Hospital mortality was 86.6% and 95.9%, respectively.
88 yte differentiation into mo-DCs and mo-Macs, respectively.
89 .6%, 57.1%, and 44.6% for the three methods, respectively.
90 e group were 152 +/- 10 and 178 +/- 9 mg/dL, respectively.
91 control of male and female sexual behavior, respectively.
92 olateral domains of polarized hepatic cells, respectively.
93 continuous pressure control by 65% and 72%, respectively.
94 and a quasiperiodic solution on a two-torus, respectively.
95 d inadequate/unknown allocation concealment, respectively.
96 enerate mutations at G-C and A-T base pairs, respectively.
97 survival rates were 99%, 95%, 86%, and 76%, respectively.
98 ier than others (P = 0.0020 and P = 0.0026), respectively.
99 than conventional SC-CO2 extraction and HRE, respectively.
100 being 0.99 (0.98-1.00) and 0.97 (0.92-1.00), respectively.
101 BRAF signaling using 17-AAG and vemurafenib, respectively.
102 ith activated and repressed gene expression, respectively.
103 toring BMAL1 exclusively in skeletal muscle, respectively.
104 quences showing deamidation in both muscles, respectively.
105 tase at 44% and 87% yield of fed propionate, respectively.
106 11microg/L in must and wine model solution, respectively.
107 ella sp., Phleboviruses and Leishmania spp., respectively.
108 cificity in the Danish and Scottish cohorts, respectively.
109 eterozygous and homozygous for this antigen, respectively.
110 mber of postbaseline visits of 8.9 and 11.2, respectively.
111 .9% and 4.0% in the myopic and toric groups, respectively.
112 assigned with 120 +/- 8 and 36 +/- 4 mug/kg, respectively.
113 or restenosis at 36 months were 5% and 30%, respectively.
114 (95% CI, 36%-66%) and 30% (95% CI, 16%-45%), respectively.
115 patients with HCC underwent RS and TACE MWA, respectively.
116 samples were about 11.57%, 8.53% and 15.90%, respectively.
117 on of potassium channels and AMPA receptors, respectively.
118 in col Ialpha 1, sox 9, and aggrecan genes, respectively.
119 te/microL in PfLDH- and PfIDEh-based assays, respectively.
120 rasites/microL and 200-400 parasites/microL, respectively.
121 .8 for the comprehensive complication index, respectively.
122 ed rates of mortality were 60.2 versus 40.4, respectively.
123 body b12, at resolutions of 3.7 A and 3.6 A, respectively.
124 rom CH12F3 cells and primary murine B cells, respectively.
125 -glucosidase, with IC50=9.89 and 8.05mug/mL, respectively.
126 he binding of information and gaze function, respectively.
127 e for red, green and blue color recognition, respectively.
128 .74) for (68)Ga-DOTATOC and (68)Ga-DOTATATE, respectively.
129 ecreasing and increasing firing reliability, respectively.
130 ion of G6pase and inhibition of glucokinase, respectively.
131 ted extremity injury and traumatic injuries, respectively.
132 d using spectrophotometry-UV and GC-MS-SPME, respectively.
133 0.78 (patient 2), and 22 and 11 (patient 3), respectively.
134 fluorescent staining and the PNA-Fish assay, respectively.
135 ha(-1), 8131.8 kg ha(-1) and 24.2 kg kg(-1), respectively.
136 d ellipsoid zone (EZ) on FAF and OCT images, respectively.
137 s and generations of chains of transmission, respectively.
138 d using Cohen's kappa and linear regression, respectively.
139 uples [Fe(CN)6](-3/-4) and [Ru(NH3)6](+3/+2) respectively.
140 ing were 73 +/- 30 nmol/kg and 28 +/- 12 nM, respectively.
141 t receptor and in mediating membrane fusion, respectively.
142 xylitol production and yield by 41% and 46%, respectively.
143 PS-M compared to the SMPS for LSHFO and MGO, respectively.
144 detection are 30-1000microM and 24.9microM, respectively.
145 be 1.62x10(-3)microM and 6.14x10(-3)microM, respectively.
146 f 1.99 x 10(4) cfu mL(-1) and 50 cfu mL(-1), respectively.
147 res of NAFL onset and NAFL-NASH progression, respectively.
148 <12m declined 74% (55-85%) and 43% (4-68%), respectively.
149 for patients with "other" ethnic background, respectively.
150 activity with veratridine and tetrodotoxin, respectively.
151 s/BPDT/AuE and the AgNPs/BPDT/AuE platforms, respectively.
152 0 genes in the leaf and tuber transcriptome, respectively.
153 tration factors of 4 and 72 for PHE and PYR, respectively.
154 48,836/QALY, $24,949/QALY, and $19,222/QALY, respectively.
155 icrom, 400 or 1200 microm and 360 or 150 Gy, respectively.
156 6 A (MOF-1201) and 4.6 and 5.6 A (MOF-1203), respectively.
157 et for "on ART" and for "viral suppression," respectively.
158 lesions was 15.7%, 33.1%, 70.5%, and 90.7%, respectively.
159 : 1.14, 1.51) and 1.07 (95% CI: 0.97, 1.18), respectively.
160 g asthma status were 97%, 95%, 90%, and 98%, respectively.
161 0.737, P < 0.001) and OPN(0.713, P < 0.001), respectively.
162 ls made of the quasi-3D bowtie nanoantennas, respectively.
163 control subjects, 654 and 328 developed AF, respectively.
164 and 7.6% (95% CI, 5.5-9.7) in the SVG group, respectively.
165 509 (p-value < 0.001) for males and females, respectively.
166 rrence at 1 and 5 years were 5.7% and 12.8%, respectively.
167 ith LVNC prevalence of 39%, 23%, 25% and 3%, respectively.
168 the oxidative stabilization of ROO and RSO, respectively.
169 ns of 0.79% (SD, 0.24) and 0.76% (SD, 0.18), respectively.
170 olymerase chain reaction and immunoblotting, respectively.
171 talizations, and vascular access thrombosis, respectively.
172 ithin 6 months (n=5420) and 1 year (n=6840), respectively, 10.2% (n=555) and 10.6% (n=724) of SHIFT-t
173 , complete remission, and partial remission, respectively; 27% in children with a genetic diagnosis;
174 aline phosphatase grade 3/4 toxicities were, respectively, 3%, 10%, and 0% for CP-A; 14%, 12%, and 6%
178 participants vs 42 [49%] of 86 participants, respectively, adjusted odds ratio [aOR] 0.46, 95% CI 0.2
179 tality (6, 17, and 29% for the three groups, respectively) all significantly increased from one group
180 then La-Ce-Nd-Sm, Lu(Yb), and Hf, Th, and U, respectively) along with an additional, in-house prepare
181 ly lower response rate (21% vs. 31% and 49%, respectively) and an aging workforce that is less likely
182 R 0.83, 95% CI 0.77-0.88 vs 0.73, 0.69-0.77, respectively) and from 1999 to 2006 (1.15, 0.91, 0.86-0.
183 contrast-enhancing and nonenhancing regions, respectively) and in normal-appearing white matter (P <
184 di- and trimethylation (H3K9me2 and H3K9me3, respectively) and the formation of heterochromatin.
185 (+/- 10.1) years and 36.1 (+/- 6.2) kg/m(2), respectively, and 82% had stage I or II breast cancer.
186 SUVmax cutoff of greater than 1.32 and 1.88, respectively, and 95.2% and 80% for a retention index of
187 -4.36, -1.77) decline in HOMA-IR and insulin respectively, and a 2.55% (95% CI, 0.93, 4.21) increase
188 forelimb area control reaching or grasping, respectively, and both are required in the transitional
189 ermanent porosity of 430 and 160 m(2) g(-1), respectively, and can encapsulate an agriculturally impo
190 peptides with LOD and LOQ at 1.2 and 2.4 pg, respectively, and high reproducibility with interday CVs
191 n response to stromal signals HGF and IGF-1, respectively, and IGF-1 expression was regulated by the
193 ent or modest inhibitors of HIV-1 infection, respectively, and that suppression corresponds to defect
194 ed cells were 0.16-0.51 h(-1) and 1.4-4.3 h, respectively, and the 1-octyne controls ranged from 0.01
195 9.5% and 9.2% for the 400- and 800-mg arms, respectively, and the estimated 10-year overall survival
196 e used to quantify volatile and ionic PFASs, respectively, and the total oxidizable precursor (TOP) a
197 nts versus nonrecipients were 38.5 and 32.9, respectively, and the unadjusted rates of mortality were
198 d specificity of MR imaging were 96% and 78% respectively, and those of mammography were 31% and 89%,
199 xpression of HHIP and FAM13A in lung tissue, respectively; and were genome-wide significant in a meta
200 and ventral premotor cortices (PMd and PMv, respectively) are two specialized areas involved in the
201 tainment of self-harm and violent offending, respectively, as adverse outcomes at ages 15-35 years.
202 nts in the 70-mg and 140-mg erenumab groups, respectively, as compared with 2.4 points in the placebo
203 nts in the 70-mg and 140-mg erenumab groups, respectively, as compared with 3.3 points in the placebo
204 with the CTX arm, with values of 4% and <1%, respectively, at month 3, 8% and 2% at month 6, 14% and
205 Tiredness score (3.2+/-17.7 and 3.8+/-18.4, respectively; between-group difference, 0.4; 95% CI, -2.
206 and PC3-TXR cells was 55.6 and 2,580 nmol/L, respectively, but decreased to 49.8 and 93.2 nmol/L when
207 RSMRs and 30-day RSMRs were 6.0% and 14.6%, respectively, but the correlation between the 2 was mode
209 everolimus-treated and CNI-treated patients, respectively, by month 12 (P = 0.018) and 2.3% (8/353) a
211 ed], and high-grade [poorly differentiated], respectively), chromogranin A, and proliferation index (
212 sites showed higher efficiency (62% and 47%, respectively) compared with the enzyme in SiO2aptms.
213 CI, 0.96-1.01) and 1.70 (95% CI, 0.36-7.93), respectively, compared with recipients without DGF.
214 re approximately twofold and fivefold lower, respectively, compared with those of gadopentetate dimeg
216 osterone (DHEA) and androstenedione (Andro), respectively, critical for generating glucocorticoids an
218 and ventral premotor cortices (PMd and PMv, respectively) each take part in unique aspects for the p
222 quantification limit were 1.43 and 4.77mg/ml respectively for sheep milk and, 2.25 and 7.5mg/ml respe
224 e interval, 1.57-4.34) and 1.79 (1.06-3.03), respectively, for fatal CHD, and 1.47 (1.13-1.91) and 1.
228 in the DMN and baseline parasympathetic tone respectively, highlighting the importance of individual
229 ty acids (linoleic and alpha-linolenic acid, respectively) in the cytochrome P450/soluble epoxide hyd
230 a cariogenic or periopathogenic microbiota, respectively, in a chain of self-reinforcing events.
231 ownstream on the top and bottom DNA strands, respectively, in an NTP-hydrolysis dependent reaction.
232 ], 11 to 17) and 54 days (95% CI, 43 to 64), respectively, in serum; 8 days (95% CI, 6 to 10) and 39
233 sistent with K(+) accumulation or depletion, respectively, in the extracellular space, which we attri
234 ponse were 3.80%, 10.13%, 45.57%, and 40.50% respectively, in the HCV group, and the corresponding ra
235 ow redox potentials around -260 and -230 mV, respectively, in the Q-binding site, respectively, sugge
236 for approximately 120min at 5 and 10mgL(-1), respectively, in treatments with O3 as gas and dissolved
237 he membrane domain of subunit b or the OSCP, respectively, in which the corresponding genes, ATP5F1 a
238 otein (19.52% and 15.81%, seeds and mucilage respectively), insoluble/soluble dietary fiber ratio (4.
240 by 0.68 and 1.75 kg in the IN and RE groups, respectively (mean difference: -1.06 kg; 95% CI: -2.75,
241 -79 years] vs 61 years [range, 46-75 years], respectively), mean duration of diabetes (10 years [rang
243 ied by the synaptic accumulation or removal, respectively, of the AMPA-receptor regulatory scaffold p
244 accomplished by activation and reactivation, respectively, of the memory-holding cells (engram cells)
245 (P=0.020), 25% (P=0.009), and 18% (P=0.004), respectively, over a total of 20 years of follow-up.
250 +/- 4 and 23 +/- 4% after 48 h and 14 days, respectively (P < 0.01); the plasma C-peptide response r
254 ia groups (469 HU +/- 167 vs 447 HU +/- 166, respectively [P = .241]; 95% confidence interval: -15.1,
258 ss registry, both at 30 days (8.2% vs. 0.7%, respectively; p = 0.0001) and at 1 year (19.7% vs. 9.8%,
262 .0 compared with -0.03 +/- 2.8 mg . min(-1), respectively; P = 0.9) or first-phase insulin secretion
265 l subjects (average of 14+/-9% and 19+/-22%, respectively; P<0.01 for both), which persisted 24 h lat
267 ta (3.4 versus 2.3 m/s for PAH and controls, respectively; P=0.001) and reduced aortic strain (23% ve
268 ein in the placebo, VP100, and VP250 groups, respectively (placebo vs VP100, P = .014; placebo vs VP2
269 5% RH and 45% for delta-MnO2 and gamma-MnO2, respectively, possibly due to their different crystal st
270 thromboplastin time (APTT) of 14.2 and 35.5s respectively, revealed high biocompatibility of the nano
271 wn to bind selectively to CD36 and exhibited respectively significant antiangiogenic and slight angio
272 and PBAF complexes, enhancers and promoters, respectively, suggesting that each complex has distinct
273 230 mV, respectively, in the Q-binding site, respectively, suggesting that release of the Q toward th
274 ve spreading depolarizations (6/7 and 10/12, respectively) than those without frontal brain lesions (
277 function at the vacuole and plasma membrane, respectively, to create membrane domains that partition
278 Ru3Rh can be reduced by 10 and 13 electrons, respectively, to final states with all bridging ligands
279 er as baseline categories for women and men, respectively-to examine whether people from sexual minor
280 izer and pet waste dominated N and P inputs, respectively, underscoring the importance of household a
281 tients treated with anti-CTLA4 and anti-PD1, respectively, we find that B2M LOH is enriched threefold
282 that 52% and 48% of the identified peptides, respectively, were affected by PTMs, with a total of 277
283 of 9.5 and 6.8 positive GM and PCR samples, respectively), whereas both possible IA cases were detec
284 of symptomatic patients (P=0.021 and P=0.05, respectively), whereas CE grade and the presence of neov
285 andard were 81% (60%-93%) and 85% (65%-95%), respectively, whereas specificity (95% CI) was 81%(62%-9
286 went VF, FP, and OOI were 63%, 22%, and 54%, respectively, whereas the proportions were 35%, 19%, and
287 d by an average of 9.4 and 5.1 Mg C ha(-1) , respectively, which are equivalent to increases of 73% a
289 d 1590 pg m(-3) for 6:2, 8:2, and 10:2 FTOH, respectively, which is 30 to 50% lower than the median c
290 50 mV s(-1) is 825, 615, and 550 mA cm(-1), respectively, which is significant dominated by the char
291 were cross-linked in open and closed states, respectively, which suggests that their actions are medi
293 with elevated or suppressed oligomerization respectively, which we use to tune the levels of Raf/MEK
294 d 2.10 +/- 1.77 in 10(8) normal nucleotides, respectively, which were significantly higher than those
295 0.5ngg(-1) and 9.2+/-0.2mugg(-1), dry basis, respectively), while their lowest amount was found in th
296 2.6mug/kg in green beans and chili peppers, respectively, while for oxamyl the LOQs were 2.9 and 0.6
297 ISSR were 0.4498, 0.3203, 0.2878 and 1.2371 respectively, while SCoT had 0.4808, 0.4522, 0.0594 and
298 y MIT at <15, 15-64, and >/=65 years of age, respectively, while the average increase in the monthly
299 lated for LTA, LPS, Poly(dT), and Poly(I:C), respectively, with at least a 1-fold change relative to
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。